Источники. 1. Ford, A.R., Hormones: getting out of hand, in: McDonnell, K

1. Ford, A.R., "Hormones: getting out of hand", in: McDonnell, K. (ed.), Adverse Effects; Women and the Pharmaceutical Industry, Penang, IOCU, 1986, pp27-40.

2. Advertisement, MIMS Caribbean, January 1991, inside front cover.

3. QIMP, Vol 22, Nos 1/2, Mar-Aug 1990, facing p70.

4. Coney, S., "The exploitation of fear: hormone replacement therapy and the menopausal woman", in: Davis, P. (ed.), For Health or Profit?: Medicine, the Pharmaceutical Industry, and the State in New Zealand, Auckland, Oxford University Press, 1992, pp179-207.

5. US Congress, Office of Technology Assessment, The Menopause, Hormone Therapy, and Women's Health, OTA-BP-BA-88, Washington, US Government Printing Office, May 1992, p71.

6. Anon., "Top 25 products in 1991", Scrip, No 1717, 13 May 1992, p28.

7. Anon., "New products boost AHP in 1992", Scrip, 1817, 4 May 1993, pp18-19.

8. Coney, op cit.

9. Roberts, P.J., "The menopause and hormone replacement therapy: views of women in general practice receiving hormone replacement therapy", British Journal of General Practice, Vol 41, Oct 1991, pp421-4.

10. Lock, M., "Contested meanings of the menopause", Lancet, Vol 337, 25 May 1991, pp1270-2.

11. National Women's Health Network, Taking Hormones and Women's Health: Choices, Risks, Benefits, Washington, 1989, pp2 and 6.

12. Ford, op cit.

13. Coney, op cit.

14. Grady, D. and Ernster, V., "Invited commentary: Does postmenopausal therapy cause breast cancer?", American Journal of Epidemiology, Vol 134, No 12, 1991, pp1396-1400.

15. Anon., "FDA committee recommends approval of oestrogen/progestogen use", Scrip, No 1632, 1O Jul 1991, p24.

16. Sillero-Arenas, M., Delgado-Rodriguez, M., et al, "Menopausal hormone replacement therapy and breast cancer: a meta-analysis", Obstetrics and Gynecology, Vol 79, No 2, Feb 1992, pp286-94.

17. Anon., "Breast cancer risk with long-term HRT", Scrip, No 1613, 3 May 1991, p25.

18. Grady and Ernster, op cit.

19. Bergkvist, L., Adami, H-0., et al, "The risk of breast cancer after estrogen and estrogen-progestin replacement", New England Journal of Medicine, Vol 321, No 5, 3 Aug 1989, pp293-7.

20. Sillero-Arenas, et al, op cit.

21. Colditz, G.A., Stampfer, M.J., et al, "Prospective study of estrogen replacement therapy and risk of breast cancer in postmenopausal women", Journal of the American Medical Association, Vol 264, No 20, 28 Nov 1990, pp2648-53.

22. Goddard, M.K., "Hormone replacement therapy and breast cancer, endometrial cancer and cardiovascular disease: risks and benefits", British Journal of General Practice, Vol 42, Mar 1992, pp 120-5.

23. O'Donnell, M., "Improving on nature", International Management, Oct 1992, p87; Phillips, A., Rakusen, J. (eds) and the Boston Women's Health Collective, The New Our Bodies, Ourselves (2nd UK edition), London, Penguin Books, 1989, p457.

24. Styrt, B. and Sugarman, В., "Estrogens and infection", Reviews of Infectious Diseases, Vol 13, 1991, pp1139-50.

25. National Women's Health Network, op cit, p9.

26. MacLennan, A., "Women, cardiovascular disease and hormone replacement therapy", Medical Journal of Australia, Vol 156, 20 Jan 1992, pp77-8.

27. Stampfer, MJ., Colditz, G.A., et al, "Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study", New England Journal of Medicine, Vol 325, No 11, 12 Sep 1991, pp756-62.

28. Barrett-Connor, E. and Bush, T.L., "Estrogen and coronary heart disease in women", Journal of the American Medical Association, Vol 265, No 14, 10 Apr 1991, pp1861-7.

29. Urrows, S.T., Freston, M.S., and Pryor, D.L., "Profiles in osteoporosis", American Journal of Nursing, Dec 1991, ррЗЗ-39.

30. Rubin, C.D., "Southwestern Internal Medicine Conference: Age-related osteoporosis", American Journal of Medical Sciences, Vol 301, No 4, Apr 1991, pp281-98.

31. Gallagher, J.C., "Pathophysiology of osteoporosis", Seminars in Nephrology, Vol 12, No 2, Mar 1992, pp109-15.

32. Anon., The European Market for Osteoporosis Treatment Products, London, Frost and Sullivan, 1992.

33. Phillips and Rakusen, op cit, p469.

34. Rubin, op cit.

35. Prince, R.L., Smith, M., et al, "Prevention of postmenopausal osteoporosis: a comparative study of exercise, calcium supplementation, and hormone-replacement therapy", New England Journal of Medicine, Vol 325, No 17, 24 Oct 1991, pp1189-95.

36. Pitt, F.A. and Brazier, J., "Hormone replacement therapy for osteoporosis", Lancet, Vol 335, 21 Apr 1990, p978.

37. Cheung, A.P. and Wren, B.G., "A cost-effectiveness analysis of hormone replacement therapy in the menopause", Medical Journal of Australia, Vol 156, 2 Mar 1992, pp312-16.

38. Urrows, et al, op cit; US Congress, op cit, p38.

39. Stevenson, J,C., Cust, M.P., et al, "Effects of transdermal versus oral hormone replacement therapy on bone density in spinal and proximal femur in postmenopausal women", Lancet, Vol 336, 4 Aug 1990, pp265-9.

40. Browner, W.S., Seeley, D.G., et al, "Non-trauma mortality in elderly women with low bone mineral density", Lancet, Vol 338, 10 Aug 1991, pp355-8.

41. Eagan, А.В., "The estrogen fix", Ms., Apr 1989, pp38-43.

42. Breslau, N.A., "Osteoporosis: Management", Seminars in Nephrology, Vol 12, No 2, Mar 1992, pp116-26.

43. Forbes, A.P., "Fuller Albright: his concept of postmenopausal osteoporosis and what came of it", Critical Orthopaedics and Related Research, No 269, Aug 1991, pp128-141.

44. Adami, H-0., "Long-term consequences of estrogen and estrogen-progestin replacement", Cancer Causes and Control, Vol 3, 1992, pp83-90.

45. Coney, op cit.

46. Ibid.

ЭНДРЮ ЧЕТЛИ. ПРОБЛЕМНЫЕ ЛЕКАРСТВА ЭНДРЮ ЧЕТЛИ. ПРОБЛЕМНЫЕ ЛЕКАРСТВА

Содержание:: ANTIBIOTIC.ru

Дата добавления: 2015-07-17